NASDAQ · NCRA

Nocera, Inc.

$1.38 -$0.13 (-8.61%) 1D Market open

Key Metrics

$2.36M
Market cap
P/E · TTM
$8.77M
Revenue · TTM
−$3.91M
Net income
EPS · TTM $-0.28
Dividend yield
Free cash flow
Beta · 1Y 1.64
EBITDA · TTM −$3.09M
Gross margin 1.7%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 20
    From its Feb 2 high, the share price fell 92%.

    Peak close $17.20 on Feb 2; trough close $1.35 on Jul 20. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -92%
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Jul 2
    The stock moved -34.4% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Jul 2
  • Mar 13
    The stock moved -36.4% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Mar 13

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$2.36M
Enterprise value
Shares outstanding1.6M
52-wk range$0.72 – $31.50
Avg volume · 20D128.2K
Net cash
Book value / share$-0.10
ExchangeNASDAQ
About Nocera, Inc.
IPO dateAug 11, 2022
Employees20

Nocera Inc is engaged in the manufacturing of aquaculture equipment, construction of aquaculture facilities, managing and operating aquaculture facilities, and consulting for third-party operators of aquaculture facilities.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S0.27
P/FCF
EV/EBITDA
EV/Sales
Graham №

Profitability

Gross 1.7%
Operating -37.3%
Net -44.5%
FCF
ROE / ROIC -284.0% · 51.9%

Financial Health

Current ratio8.00
Quick ratio
Debt / equity
Debt / EBITDA
Net cash
Working capital$4.97M

Cash Flow · TTM

Operating CF −$3.05M
Capex
Free cash flow
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

3 / 9
Weak fundamentals · 3 of 9 signals passing

Altman Z-Score

-3.7
Distress zone (< 1.81) · elevated risk

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings